beta blocker: be effective as antianginal medications

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be effective as antianginal medications 1.00
be effective as medications 0.99
be added to medicines 0.84
be effective in cancer treatment 0.81
be added to aspirin 0.79
be contraindicated in patients with asthma 0.79
is effective 0.79
be prescribed for anxiety 0.77
is prescribed 0.77
be less effective in elderly 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.92
Similarity weight: 0.81
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)
0.36
Rule weight: 0.66
Evidence weight: 0.64
Similarity weight: 0.84
Evidence: 0.27
Plausible(agent, be added to medicines) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)
0.29
Rule weight: 0.66
Evidence weight: 0.55
Similarity weight: 0.79
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.96
Similarity weight: 0.79
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.10
¬ Plausible(agent, be added to aspirin)
0.07
Rule weight: 0.09
Evidence weight: 0.88
Similarity weight: 0.84
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.27
¬ Plausible(agent, be added to medicines)
0.05
Rule weight: 0.09
Evidence weight: 0.63
Similarity weight: 0.81
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)

Remarkability exclusitivity betweem a parent and a child

0.43
Rule weight: 0.58
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin)
0.41
Rule weight: 0.58
Evidence weight: 0.85
Similarity weight: 0.84
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.17
¬ Remarkable(agent, be added to medicines)
0.30
Rule weight: 0.58
Evidence weight: 0.65
Similarity weight: 0.81
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 0.77
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.77
¬ Remarkable(atenolol, is prescribed)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)
0.33
Rule weight: 0.42
Evidence weight: 0.93
Similarity weight: 0.84
Evidence: 0.27
Plausible(agent, be added to medicines) ⋁
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)
0.30
Rule weight: 0.42
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)

Remarkability from sibling implausibility

0.43
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.77
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.77
Remarkable(atenolol, is prescribed) ⋁
Evidence: 0.59
¬ Plausible(atenolol, is prescribed)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.67
Similarity weight: 1.00
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.76
¬ Salient(beta blocker, be effective as antianginal medications)

Similarity expansion

0.60
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.60
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.77
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
0.58
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.79
¬ Remarkable(beta blocker, is effective)
0.58
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.72
¬ Remarkable(beta blocker, be prescribed for anxiety)
0.54
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.77
Evidence: 0.76
Salient(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.76
¬ Salient(beta blocker, be prescribed for anxiety)
0.53
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.76
Salient(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.76
Salient(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.81
¬ Salient(beta blocker, be less effective in elderly)
0.52
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.79
Evidence: 0.76
Salient(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.94
¬ Salient(beta blocker, is effective)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.77
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.64
¬ Plausible(beta blocker, be prescribed for anxiety)
0.45
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.79
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.45
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.77
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.64
¬ Typical(beta blocker, be prescribed for anxiety)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be less effective in elderly)
0.43
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.79
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.82
¬ Plausible(beta blocker, is effective)
0.40
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.79
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.80
¬ Typical(beta blocker, is effective)
0.40
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.79
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)
0.37
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.77
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.76
Salient(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.57
Plausible(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)

Typicality and Rermarkability incompatibility between a parent and a child

0.28
Rule weight: 0.51
Evidence weight: 0.68
Similarity weight: 0.79
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.38
¬ Typical(agent, be added to aspirin)
0.24
Rule weight: 0.51
Evidence weight: 0.56
Similarity weight: 0.84
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.53
¬ Typical(agent, be added to medicines)
0.09
Rule weight: 0.51
Evidence weight: 0.22
Similarity weight: 0.81
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.77
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.56
¬ Typical(atenolol, is prescribed)

Typicality inheritance from parent to child

0.31
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.38
¬ Typical(agent, be added to aspirin)
0.30
Rule weight: 0.48
Evidence weight: 0.73
Similarity weight: 0.84
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.53
¬ Typical(agent, be added to medicines)
0.21
Rule weight: 0.48
Evidence weight: 0.53
Similarity weight: 0.81
Evidence: 0.50
Typical(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)